KR870010080A - 면역촉진 활성을 갖는 트리펩티드 - Google Patents
면역촉진 활성을 갖는 트리펩티드 Download PDFInfo
- Publication number
- KR870010080A KR870010080A KR870003455A KR870003455A KR870010080A KR 870010080 A KR870010080 A KR 870010080A KR 870003455 A KR870003455 A KR 870003455A KR 870003455 A KR870003455 A KR 870003455A KR 870010080 A KR870010080 A KR 870010080A
- Authority
- KR
- South Korea
- Prior art keywords
- tripeptide
- immunostimulatory activity
- arg
- ala
- trifluoroacetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000003308 immunostimulating effect Effects 0.000 title claims 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000000987 immune system Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 238000010586 diagram Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
- C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20027/86A IT1188646B (it) | 1986-04-09 | 1986-04-09 | Tripeptide ad attivita' immunostimolante |
| IT20027A | 1986-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR870010080A true KR870010080A (ko) | 1987-11-30 |
Family
ID=11163225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR870003455A Ceased KR870010080A (ko) | 1986-04-09 | 1987-04-09 | 면역촉진 활성을 갖는 트리펩티드 |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPH0645637B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR870010080A (cg-RX-API-DMAC10.html) |
| AR (1) | AR242799A1 (cg-RX-API-DMAC10.html) |
| AT (1) | ATA88387A (cg-RX-API-DMAC10.html) |
| AU (1) | AU597048B2 (cg-RX-API-DMAC10.html) |
| BE (1) | BE1000263A4 (cg-RX-API-DMAC10.html) |
| CA (1) | CA1322715C (cg-RX-API-DMAC10.html) |
| CH (1) | CH676467A5 (cg-RX-API-DMAC10.html) |
| DE (1) | DE3712050A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2003043A6 (cg-RX-API-DMAC10.html) |
| FR (1) | FR2597107B1 (cg-RX-API-DMAC10.html) |
| GB (1) | GB2189491B (cg-RX-API-DMAC10.html) |
| GR (1) | GR870568B (cg-RX-API-DMAC10.html) |
| IE (1) | IE59806B1 (cg-RX-API-DMAC10.html) |
| IT (1) | IT1188646B (cg-RX-API-DMAC10.html) |
| NL (1) | NL8700827A (cg-RX-API-DMAC10.html) |
| SE (1) | SE8701457L (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2058553C1 (ru) * | 1994-03-18 | 1996-04-20 | Иван Николаевич Головистиков | Способ определения супрессорного звена иммунного статуса человека |
| RU2056852C1 (ru) * | 1994-03-18 | 1996-03-27 | Иван Николаевич Головистиков | Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний |
| GB0130286D0 (en) * | 2001-12-19 | 2002-02-06 | Astrazeneca Ab | Chemical process |
| GB0130285D0 (en) * | 2001-12-19 | 2002-02-06 | Astrazeneca Ab | Chemical process |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3778426A (en) * | 1970-12-16 | 1973-12-11 | Research Corp | Therapeutically useful polypeptides |
| US4215112A (en) * | 1979-03-14 | 1980-07-29 | Ortho Pharmaceutical Corporation | Tripeptides and methods |
-
1986
- 1986-04-09 IT IT20027/86A patent/IT1188646B/it active
-
1987
- 1987-04-06 IE IE88187A patent/IE59806B1/en not_active IP Right Cessation
- 1987-04-07 CH CH1336/87A patent/CH676467A5/it not_active IP Right Cessation
- 1987-04-07 SE SE8701457A patent/SE8701457L/ not_active Application Discontinuation
- 1987-04-08 CA CA000534201A patent/CA1322715C/en not_active Expired - Fee Related
- 1987-04-08 NL NL8700827A patent/NL8700827A/nl not_active Application Discontinuation
- 1987-04-08 AU AU71182/87A patent/AU597048B2/en not_active Ceased
- 1987-04-09 FR FR878705021A patent/FR2597107B1/fr not_active Expired - Fee Related
- 1987-04-09 JP JP62087896A patent/JPH0645637B2/ja not_active Expired - Lifetime
- 1987-04-09 GB GB8708492A patent/GB2189491B/en not_active Expired - Fee Related
- 1987-04-09 KR KR870003455A patent/KR870010080A/ko not_active Ceased
- 1987-04-09 DE DE19873712050 patent/DE3712050A1/de active Granted
- 1987-04-09 GR GR870568A patent/GR870568B/el unknown
- 1987-04-09 AT AT0088387A patent/ATA88387A/de not_active Application Discontinuation
- 1987-04-09 BE BE8700377A patent/BE1000263A4/fr not_active IP Right Cessation
- 1987-04-09 AR AR87307260A patent/AR242799A1/es active
- 1987-04-09 ES ES8701042A patent/ES2003043A6/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU597048B2 (en) | 1990-05-24 |
| NL8700827A (nl) | 1987-11-02 |
| IT8620027A0 (it) | 1986-04-09 |
| GB2189491B (en) | 1990-02-21 |
| SE8701457L (sv) | 1987-10-10 |
| IT1188646B (it) | 1988-01-20 |
| IT8620027A1 (it) | 1987-10-09 |
| FR2597107B1 (fr) | 1991-02-22 |
| SE8701457D0 (sv) | 1987-04-07 |
| IE870881L (en) | 1987-10-09 |
| ATA88387A (de) | 1996-05-15 |
| DE3712050A1 (de) | 1987-10-15 |
| FR2597107A1 (fr) | 1987-10-16 |
| AR242799A1 (es) | 1993-05-31 |
| JPS62267296A (ja) | 1987-11-19 |
| IE59806B1 (en) | 1994-04-06 |
| GR870568B (en) | 1987-08-12 |
| GB2189491A (en) | 1987-10-28 |
| CH676467A5 (cg-RX-API-DMAC10.html) | 1991-01-31 |
| DE3712050C2 (cg-RX-API-DMAC10.html) | 1992-02-13 |
| BE1000263A4 (fr) | 1988-09-27 |
| ES2003043A6 (es) | 1988-10-01 |
| CA1322715C (en) | 1993-10-05 |
| AU7118287A (en) | 1987-10-15 |
| JPH0645637B2 (ja) | 1994-06-15 |
| GB8708492D0 (en) | 1987-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2058796T3 (es) | Aislamiento y elucidacion estructural del depsipeptido citostatico lineal dolastatina 15. | |
| CA2029678A1 (en) | Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14 | |
| DK642587A (da) | Insulinpraeparat | |
| KR880000098A (ko) | 콘드로이틴 설페이트 면역자극 조성물 | |
| MXPA02007931A (es) | Analogos de nucleosido con base monociclica modificada con carboxamidina. | |
| ES2009216A6 (es) | Metodo de preparar un derivado de interleucina-lalfa. | |
| IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
| AR012614A1 (es) | Una composicion farmaceutica para la fabricacion de un medicamento destinado para el tratamiento de una infeccion viral susceptible de tratamientocon interferon alfa, un metodo para la fabricacion de un medicamento, el uso de peg12000-ifn alfa para la fabricacion de un medicamento | |
| ES2179040T3 (es) | Utilizacion de 5-fluoro-2'-desoxi-3'-tiacitidina para el tratamiento de la hepatitis b. | |
| AU7589587A (en) | Low dosage of interferon to enhance vaccine efficiency | |
| ES2062137T3 (es) | Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea. | |
| JPS52139713A (en) | Sustained release cefalexin preparations | |
| ATE90872T1 (de) | Immunostimulierende arzneimittel. | |
| KR870010080A (ko) | 면역촉진 활성을 갖는 트리펩티드 | |
| AU2426592A (en) | New ganglioside derivatives | |
| GB8611946D0 (en) | Pharmaceutical preparations | |
| NO881778D0 (no) | Inkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater. | |
| KR870010079A (ko) | 면역촉진 활성을 갖는 트리펩티드 | |
| IE891296L (en) | A synthetic vaccine against foot and mouth disease and a¹process for the preparation thereof | |
| GB8925896D0 (en) | Indole derivatives,their preparation and use as medicament | |
| GB1351437A (en) | N-substituted amino acids having antiviral anti-inflammatory or anti-tumour activity | |
| MY114218A (en) | The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations. | |
| GB1363801A (en) | Peptides and their preparation | |
| ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
| AU7111587A (en) | Perhydrothiazepine and perhydroazepine derivatives,their preparation and their therapeutic use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19870409 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19920313 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19870409 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19950919 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19960309 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19950919 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |